Lung Disease News and Research

RSS

New Poll: 9 out of 10 Ontarians would support an investment in lung health

According to a new Leger Marketing poll conducted for the Ontario Lung Association, 9 out of 10 of Ontarians would support the Ontario government investing in lung health today if it would save future healthcare spending.

22 Sep 2011

NEJM publishes Boehringer Ingelheim's BIBF 1120 phase II trial on IPF

Boehringer Ingelheim's investigational tyrosine kinase inhibitor (TKI) BIBF 1120 demonstrated a positive trend in reducing lung function decline in patients with idiopathic pulmonary fibrosis (IPF), according to phase II clinical trial results published today online in the New England Journal of Medicine.

22 Sep 2011

Individuals without ubiquitin ligase Nedd4L more likely to develop CF

Cystic fibrosis (CF), a chronic disease that clogs the lungs and leads to life-threatening lung infections, is caused by a genetic defect in a chloride channel called cystic fibrosis transmembrane conductase regulator.

20 Sep 2011

WHO, WEF reports examine cost of treating and preventing, economic burden of NCDs

Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.

20 Sep 2011

Roxon plans to propagate tough stands on tobacco packaging

Health Minister Nicola Roxon plans to encourage other countries to follow Australia's push for plain-packaged tobacco at a major United Nations summit on chronic diseases today.

19 Sep 2011

Advocates ramp up efforts to protect Medicaid from 'super committee' trims

State Medicaid directors as well as patient and consumer advocates are detailing the harms that would result from various Medicaid changes under discussion.

16 Sep 2011

Scientists uncover unknown fail-safe pathway for inherited disorders

Scientists at the University of California, San Diego School of Medicine have uncovered a previously unknown fail-safe (compensatory) pathway that potentially protects the brain and other organs from genetic and environmental threats.

16 Sep 2011

Breast and cervical cancers on the rise in poor nations

A new global analysis of diseases has revealed that the number of cases and deaths from breast and cervical cancer is rising in most countries across the world, especially in poorer nations where more women are dying at younger ages.

15 Sep 2011

InterMune to launch Esbriet for German patients with IPF

InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.

12 Sep 2011

Non-communicable disease epidemic a global problem

Later this month the United Nations will convene a high-level meeting on non-communicable diseases. The world's global health news has been so dominated by infectious culprits - HIV/AIDS, malaria, tuberculosis, influenza - that it's easy to forget just how big a toll conditions like diabetes, cancer and heart and lung disease take say experts.

9 Sep 2011

World Cancer Research Fund urges action to stop preventable cancers

According to the WCRF this Wednesday healthier lifestyles and better diets could prevent up to 2.8 million cases of cancer each year. The WCRF called upon governments to “avoid a public health disaster”.

8 Sep 2011

ERS urges EU to take action on chronic respiratory diseases

Respiratory diseases are one of the leading causes of death and suffering in the EU. The challenge Europe is facing in this field goes far beyond public health: lung diseases currently cause an annual cost of €100 billion and threaten the Europe 2020 strategy and the goal to have 75% of the working population employed and productive.

6 Sep 2011

Azithromycin can help reduce wheezing, other acute symptoms of COPD

A common antibiotic can help reduce the severe wheezing and other acute symptoms of chronic obstructive pulmonary disease, according to a large, multicenter clinical trial sponsored by the National Institutes of Health and conducted at the University of California, San Francisco (UCSF).

29 Aug 2011

Amniotic fluid-derived stem cells show promise against lung disease

Two papers published in the current issue of Cell Transplantation, highlight the rich source of stem cells in human amniotic fluid that can be isolated and transplanted for therapeutic purposes.

25 Aug 2011

New tool can identify patients at high risk of venous thromboembolism

A new risk prediction tool can identify patients at high risk of serious blood clots (known as venous thromboembolism) who might need preventative treatment, says a study published on bmj.com today.

17 Aug 2011

Seattle Children's receives Gates Foundation grant to complete development of Sea-PAP

Seattle Children's Research Institute today announced the receipt of a two-year, $2.3 million grant from the Bill & Melinda Gates Foundation to complete prototype development of its new respiratory support device, called Seattle Children's Positive Airway Pressure.

17 Aug 2011

Study helps clarify definition of gastroesophageal reflux disease

Modifying stomach acid levels may not be enough to treat symptoms in neonates suspected of having gastroesophageal reflux disease. According to a study from Nationwide Children's Hospital, this is the first study to classify reflux and its associated symptoms in neonates based on how and what is refluxed.

9 Aug 2011

Insmed second quarter revenues decrease to $1.0 million

Insmed Incorporated, a biopharmaceutical company, today reported results for the second quarter and six-months ended June 30, 2011.

8 Aug 2011

Insmed receives FDA clinical hold order for ARIKACE phase 3 trials in CF and NTM

Insmed Incorporated, a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the agency has placed a clinical hold on Insmed's phase 3 clinical trials for ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections and patients with non-tuberculous mycobacterial (NTM) lung disease.

2 Aug 2011

Tunstall Healthcare launch new myclinic@home telehealth solution

myclinic@home is the latest in telehealth solutions, allowing remote patients to easily monitor their vital signs and manage a long term health condition in the comfort of their own home or a clinic setting, all supported by a health professional.

1 Aug 2011